Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MCF7 | BMS-265246 | 0.031622777 | 0.3651 | 0.03823 |
| MCF7 | BMS-265246 | 0.031622777 | 0.3723 | 0.03574 |
| MCF7 | BMS-265246 | 0.1 | 0.1912 | 0.02826 |
| MCF7 | BMS-265246 | 0.1 | 0.1854 | 0.01411 |
| MCF7 | BMS-265246 | 0.1 | 0.3205 | 0.04034 |
| MCF7 | BMS-265246 | 0.316227766 | 0.1845 | 0.03668 |
| MCF7 | BMS-265246 | 0.316227766 | 0.1845 | 0.03580 |
| MCF7 | BMS-265246 | 0.316227766 | 0.1695 | 0.03514 |
| MCF7 | BMS-265246 | 1.0 | 0.0552 | 0.03022 |
| MCF7 | BMS-265246 | 1.0 | 0.0780 | 0.05002 |
| MCF7 | BMS-265246 | 1.0 | 0.2041 | 0.03178 |
| MCF7 | BMS-265246 | 3.16227766 | 0.0746 | 0.03041 |
| MCF7 | BMS-265246 | 3.16227766 | 0.0375 | 0.00390 |
| MCF7 | BMS-265246 | 3.16227766 | 0.1051 | 0.02875 |
| MCF7 | BMS-265246 | 10.0 | 0.0399 | 0.02795 |
| MCF7 | BMS-265246 | 10.0 | 0.0723 | 0.02462 |
| MCF7 | BMS-265246 | 10.0 | 0.1126 | 0.03475 |
| MCF7 | Ulixertinib | 0.001 | 1.0542 | -0.00134 |
| MCF7 | Ulixertinib | 0.001 | 1.0376 | 0.00173 |
| MCF7 | Ulixertinib | 0.001 | 1.1383 | -0.00283 |
| MCF7 | Ulixertinib | 0.003162278 | 1.0595 | -0.00323 |
| MCF7 | Ulixertinib | 0.003162278 | 1.0529 | -0.00099 |
| MCF7 | Ulixertinib | 0.003162278 | 1.0346 | -0.00248 |
| MCF7 | Ulixertinib | 0.01 | 0.9509 | -0.00122 |
| MCF7 | Ulixertinib | 0.01 | 0.9759 | -0.00097 |